TREATMENT PHARMA ApS: Financial statements 2025
CVR: 37208035
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
TREATMENT PHARMA ApS (CVR 37208035) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 410,337 and a net result of DKK 101,980 compared with DKK -38,290 the year before. Equity in the 2025 report amounted to DKK 187,516. The solvency ratio was 36.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 410,337
- Profit/Loss
- DKK 101,980
- Equity
- DKK 187,516
- Total Assets
- DKK 512,257
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 410 t. | 102 t. | 188 t. | 1 |
| 2024 | - | -37 t. | -38 t. | 86 t. | 0 |
| 2023 | - | -45 t. | -47 t. | -76 t. | 1 |
| 2022 | - | -23 t. | -24 t. | -29 t. | - |
| 2021 | - | -3 t. | -3 t. | -5 t. | - |
Official annual report
How creditworthy is TREATMENT PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of October 3, 2025, Anne Simmenæs Holding ApS is registered as an owner of TREATMENT PHARMA ApS with an ownership share of 33%.
TREATMENT PHARMA ApS has published its annual report for 2024. Gross profit came to DKK -36,904, and the net result was DKK -38,290.
About TREATMENT PHARMA ApS
TREATMENT PHARMA ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2015. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named TREATMENT ApS. The management consists of Anne Simmenæs. The company is owned by Tove Resen Holding ApS, Power the Future ApS and Anne Simmenæs Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 410,337 and a net result of DKK 101,980 compared with DKK -38,290 the year before. Equity in the 2025 report amounted to DKK 187,516.